Skip to main content

Asset Dedication, LLC

SEC CIK
0001475896
Latest filing
Jul 30, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Asset Dedication, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
6
Value
$1.81K
% of portfolio
<0.1%
Quarters held
6
Since Q3 2021
Holdings of ALNY by Asset Dedication, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266$1.81K<0.1%+1+20.0%AddedHolders
Q1 20265$1.66K<0.1%00.0%UnchangedHolders
Q4 20255$1.99K<0.1%00.0%UnchangedHolders
Q3 20255$2.28K<0.1%+5NewHolders
Q1 20230$00.0%−1−100.0%Sold outHolders
Q4 20221$00.0%+1NewHolders
Q4 20210$00.0%−16−100.0%Sold outHolders
Q3 202116$3.00K<0.1%+16NewHolders